JNJ — Research

Johnson & Johnson · Healthcare · $152.18

Dividend Score

Valuation Score

Growth Score

AI Stock Summary

Johnson & Johnson shows a mixed setup heading into the next quarter. The company maintains a defensible position in Healthcare with healthy cash generation. Momentum and sentiment indicators are currently neutral, while valuation sits near the sector median. Watch upcoming earnings and macro data for direction.

Analyst Ratings

24 analysts

Strong Buy7

Buy11

Hold3

Sell3

Avg. price target

$160.31+5.34%

Bull Case

Durable competitive moat in Healthcare with pricing power
Expanding margins and strong free cash flow conversion
Consistent capital returns and disciplined reinvestment

Bear Case

Valuation leaves limited room for execution missteps
Macro and rate sensitivity could pressure near-term demand
Rising competition may compress long-term growth rates

Fundamentals

Alpha Vantage

Loading fundamentals…

Earnings history

Alpha Vantage

Loading earnings…

News & sentiment

Alpha Vantage

Loading news…

Save JNJ and track it in your portfolio

Create a free EasytoBegin account to save stocks, build a watchlist, and track your portfolio.